Metraipolis › archive › dc_bd41df4de829
Omalizumab — Wikipedia (en)
- Source
- Wikipedia (en)
- Original
- https://en.wikipedia.org/wiki/Omalizumab
- License (as archived)
- CC-BY-SA-4.0
- Archived
- 2026-10-08T00:21:28.870Z
- SHA-256 of the archived text
e554a5fa3e5633d14a83f6859c37659c7d3c8b761d202f734c31e2931ce8248d- Stable URL of this page
https://metraipolis.com/documento/dc_bd41df4de829
How to cite
Omalizumab — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/Omalizumab (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_bd41df4de829 (Metraipolis archive dc_bd41df4de829, sha256 e554a5fa3e5633d14a83f6859c37659c7d3c8b761d202f734c31e2931ce8248d)
BibTeX
@misc{dcbd41df4de829,
title = {Omalizumab — Wikipedia (en)},
howpublished = {Wikipedia (en)},
url = {https://en.wikipedia.org/wiki/Omalizumab},
note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_bd41df4de829; sha256 e554a5fa3e5633d14a83f6859c37659c7d3c8b761d202f734c31e2931ce8248d},
year = {2026}
}Archived text
Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/Omalizumab. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Omalizumab, sold under the brand name Xolair among others, is an injectable medication to treat severe persistent allergic forms of asthma, nasal polyps, urticaria (hives), and immunoglobulin E-mediated food allergy. Omalizumab is a recombinant DNA-derived humanized IgG1 monoclonal antibody which specifically binds to free human immunoglobulin E (IgE) in the blood and interstitial fluid and to the membrane-bound form of IgE (mIgE) on the surface of mIgE-expressing B lymphocytes. In 1987, Tanox filed its first patent application on the anti-IgE drug candidate. Omalizumab was approved for medical use in the United States in June 2003, and authorized in the European Union in October 2005. Tema degli esploratori: scienze della vita e salute (deposito sistematico; ricerca «immunology»). Fonte: Wikipedia in inglese, voce «Omalizumab» — https://en.wikipedia.org/wiki/Omalizumab Wikidata Q415392 (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q415392 Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/Omalizumab?action=history). Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza. Estratto dell'introduzione non modificato nel contenuto; revisione 1372783889, consultata il 2026-10-07T23:58:54.975Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: ffac1466b7a53a61f9b87c576872f0d0275028e36df5873bb96b955c65b67763